SOLID CANCERS
Clinical trials for SOLID CANCERS explained in plain language.
Never miss a new study
Get alerted when new SOLID CANCERS trials appear
Sign up with your email to follow new studies for SOLID CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug JY016 targets tough cancers with EGFR marker in early trial
Disease control Not yet recruitingThis study tests a new drug called JY016 in 228 adults with advanced solid tumors that have a protein called EGFR. The trial has two parts: first, finding the safest dose, then testing how well it works against cancers like pancreatic, lung, and colon cancer. The goal is to contr…
Matched conditions: SOLID CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Biotech Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Scientists track immune clues in 600 early cancer patients to predict immunotherapy success
Knowledge-focused Not yet recruitingThis study will follow 600 adults with early-stage solid cancers (like lung, head and neck, melanoma, or bladder cancer) who receive immunotherapy before surgery. Researchers will collect blood and tumor samples over time to identify immune system markers that predict how well th…
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 17, 2026 04:14 UTC
-
New study aims to predict dangerous side effects of cancer immunotherapy before they happen
Knowledge-focused Not yet recruitingThis study will look at 160 adults with solid tumors who are about to start immunotherapy. Researchers will collect blood, stool, and imaging data to find patterns that could predict which patients will have severe side effects. The goal is to create a test that helps doctors pre…
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated May 08, 2026 12:00 UTC